Michael S. Brown
Known title: DirectorCIK: 0001174475
Associated companies
Transaction History
| REGN | ▲ Buy | Grant | 155 | $0 | 1/2/2026 | View on chart |
| REGN | ▲ Buy | Grant | 166 | $0 | 1/2/2025 | View on chart |
| REGN | ▲ Buy | Option Exercise | 1,535 | $960K | 6/14/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,535 | $1.6M | 6/14/2024 | View on chart |
| REGN | ▲ Buy | Option Exercise | 1,172 | $733K | 5/28/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,172 | $1.1M | 5/28/2024 | View on chart |
| REGN | ▲ Buy | Grant | 135 | $0 | 1/2/2024 | View on chart |
| REGN | ▲ Buy | Option Exercise | 2,049 | $989K | 12/27/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 2,049 | $1.8M | 12/27/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 3,070 | $1.6M | 4/21/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 3,070 | $2.5M | 4/21/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 500 | $399K | 2/6/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 3,071 | $1.6M | 2/6/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 3,071 | $2.5M | 2/6/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 1 | $520 | 1/27/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 1 | $747 | 1/27/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 3,070 | $1.6M | 1/6/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 3,070 | $2.3M | 1/6/2023 | View on chart |
| REGN | ▲ Buy | Grant | 165 | $0 | 1/3/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 1,564 | $755K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $76K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 200 | $154K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 200 | $153K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 201 | $154K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 201 | $154K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $77K | 11/8/2022 | View on chart |
| REGN | ▲ Buy | Option Exercise | 2,431 | $909K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 300 | $226K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 200 | $151K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 1,764 | $1.3M | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 203 | $153K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 200 | $153K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 126 | $95K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 200 | $152K | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 500 | $374K | 11/8/2022 | View on chart |
| REGN | ▲ Buy | Option Exercise | 408 | $153K | 3/30/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 408 | $285K | 3/30/2022 | View on chart |
| REGN | ▲ Buy | Option Exercise | 1,522 | $569K | 3/29/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 1,522 | $1.1M | 3/29/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 500 | $304K | 2/23/2022 | View on chart |
| REGN | ▲ Buy | Grant | 191 | $0 | 1/3/2022 | View on chart |
| REGN | ▲ Buy | Option Exercise | 2,479 | $944K | 9/13/2021 | View on chart |
| REGN | ▲ Buy | Option Exercise | 3,613 | $1.5M | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 676 | $432K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 203 | $130K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 200 | $127K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $64K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $64K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 400 | $257K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $64K | 9/13/2021 | View on chart |
| REGN | ▲ Buy | Option Exercise | 3,612 | $1.5M | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $64K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $64K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $65K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $65K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 151 | $98K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 962 | $624K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 838 | $544K | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 1,800 | $1.2M | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 3,712 | $2.4M | 9/13/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 62 | $40K | 9/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock
Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.
Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock. Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.